These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23163951)

  • 1. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.
    Walsh KS; Vélez JI; Kardel PG; Imas DM; Muenke M; Packer RJ; Castellanos FX; Acosta MT
    Dev Med Child Neurol; 2013 Feb; 55(2):131-138. PubMed ID: 23163951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.
    Morotti H; Mastel S; Keller K; Barnard RA; Hall T; O'Roak BJ; Fombonne E
    Dev Med Child Neurol; 2021 Feb; 63(2):226-232. PubMed ID: 32406525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1.
    Plasschaert E; Descheemaeker MJ; Van Eylen L; Noens I; Steyaert J; Legius E
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jan; 168B(1):72-80. PubMed ID: 25388972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study.
    Garg S; Lehtonen A; Huson SM; Emsley R; Trump D; Evans DG; Green J
    Dev Med Child Neurol; 2013 Feb; 55(2):139-145. PubMed ID: 23163236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
    Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
    BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders.
    Yerys BE; Wallace GL; Sokoloff JL; Shook DA; James JD; Kenworthy L
    Autism Res; 2009 Dec; 2(6):322-33. PubMed ID: 19998356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ADHD symptoms on autism spectrum disorder symptom severity.
    Sprenger L; Bühler E; Poustka L; Bach C; Heinzel-Gutenbrunner M; Kamp-Becker I; Bachmann C
    Res Dev Disabil; 2013 Oct; 34(10):3545-52. PubMed ID: 23973801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening children with neurofibromatosis type 1 for autism spectrum disorder.
    Tinker J; Carbone PS; Viskochil D; Mathiesen A; Ma KN; Stevenson DA
    Am J Med Genet A; 2014 Jul; 164A(7):1706-12. PubMed ID: 24715629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairments in communication and social interaction in children with neurofibromatosis type 1: Characteristics and role of ADHD and language delay.
    Cohen R; Halevi A; Aharoni S; Aronson B; Diamond G
    Appl Neuropsychol Child; 2022; 11(3):220-225. PubMed ID: 32569512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of ADHD on the cognitive and academic functioning of children with NF1.
    Pride NA; Payne JM; North KN
    Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1.
    Payne JM; Haebich KM; MacKenzie R; Walsh KS; Hearps SJC; Coghill D; Barton B; Pride NA; Ullrich NJ; Tonsgard JH; Viskochil D; Schorry EK; Klesse L; Fisher MJ; Gutmann DH; Rosser T; Packer RJ; Korf B; Acosta MT; Bellgrove MA; North KN
    J Atten Disord; 2021 Jun; 25(8):1177-1186. PubMed ID: 31838937
    [No Abstract]   [Full Text] [Related]  

  • 12. Autism spectrum disorder symptomatology in children with neurofibromatosis type 1.
    Payne JM
    Dev Med Child Neurol; 2013 Feb; 55(2):100-101. PubMed ID: 23320572
    [No Abstract]   [Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder symptoms in adults with autism spectrum disorders.
    Johnston K; Dittner A; Bramham J; Murphy C; Knight A; Russell A
    Autism Res; 2013 Aug; 6(4):225-36. PubMed ID: 23788522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ADHD in neurofibromatosis type 1.
    Mautner VF; Kluwe L; Thakker SD; Leark RA
    Dev Med Child Neurol; 2002 Mar; 44(3):164-70. PubMed ID: 12005317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders.
    Lee DO; Ousley OY
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):737-46. PubMed ID: 17201617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
    Payne JM; Arnold SS; Pride NA; North KN
    Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per Se.
    Lion-François L; Herbillon V; Peyric E; Mercier C; Gérard D; Ginhoux T; Coutinho V; Kemlin I; Kassai B; Desportes V; Michael GA
    J Atten Disord; 2020 Nov; 24(13):1807-1823. PubMed ID: 28587546
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinct attentional and executive profiles in neurofibromatosis type 1: Is there difference with primary attention deficit-hyperactivity disorder?
    Routier L; Querné L; Fontaine C; Berquin P; Le Moing AG
    Eur J Paediatr Neurol; 2024 Jul; 51():93-99. PubMed ID: 38905883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.
    Constantino JN; Zhang Y; Holzhauer K; Sant S; Long K; Vallorani A; Malik L; Gutmann DH
    J Pediatr; 2015 Sep; 167(3):621-6.e1. PubMed ID: 26051969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineating the autistic phenotype in children with neurofibromatosis type 1.
    Chisholm AK; Haebich KM; Pride NA; Walsh KS; Lami F; Ure A; Maloof T; Brignell A; Rouel M; Granader Y; Maier A; Barton B; Darke H; Dabscheck G; Anderson VA; Williams K; North KN; Payne JM
    Mol Autism; 2022 Jan; 13(1):3. PubMed ID: 34983638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.